SEATTLE, Oct. 20, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global charcot-marie-tooth disease market is estimated to be valued at US$ 793.9 Million in 2021 and is expected to exhibit a CAGR of 23.4% over the forecast period (2021-2028).
Key Trends and Analysis of the Global Charcot-Marie-Tooth Disease Market:
The advent of technologically advanced therapies is driving the growth of the global charcot-marie-tooth disease market. For instance, emerging therapy such as ACE-083 (Acceleron) is currently under development for the treatment of focal muscle loss. It has been designed to increase strength and function in specific target muscles for improved patient function and quality of life. It is currently under second phase of development for CMT (charcot-marie-tooth).
Furthermore, key players operating in the global charcot-marie-tooth disease market are focusing on adoption of inorganic growth strategies such as acquisition and collaboration to increase their market presence in the global market. For instance, in March 2017, MedDay acquired Profilomic’s (a company that provides biotechnology services) health division to enhance research capabilities.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4698
Key Market Takeaways:
The global charcot-marie-tooth disease market is expected to exhibit a CAGR of xx% during the forecast period, owing to the introduction of technologically advanced therapies for the treatment of CMT. For instance, according to an article published in multiple sclerosis news today, in March 2020, MD1003, a highly concentrated oral formulation of biotin (also known as vitamin H or vitamin B7) is currently being investigated clinically for the treatment of primary and secondary progressive multiple sclerosis (PPMS and SPMS) developed by the French biotechnology company MedDay Pharma. It is currently under phase III clinical trial.
Among regions, North America dominates the global charcot-marie-tooth disease market, due to strict reimbursement policies in the U.S. and increased cancer awareness and research, while Europe market is also expected to grow in the estimated period due to increasing investment in research and development and increased health spending.
Competitive Landscape:
Key players operating in the global charcot-marie-tooth disease market include Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc.
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4698
Market Segmentation:
- Global Charcot-Marie-Tooth Disease Market, By Disease Type:
-
- CMT 1
- CMT 2
- CMT 3
- Others
- Global Charcot-Marie-Tooth Disease Market, By Drug Type:
-
- Nonsteroidal anti-inflammatory drugs
- Cyclooxygenase-2 inhibitors
- Tricyclic antidepressants
- Anticonvulsants
- Analgesics
- Pipeline Drug
- Global Charcot-Marie-Tooth Disease Market, By Distribution Channel:
-
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Charcot-Marie-Tooth Disease Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- North America
-
- Asia Pacific
-
-
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
-
-
- Middle East
-
-
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
-
-
- Africa
-
-
- By Region/Country
- South Africa
- Central Africa
- North Africa
- By Region/Country
-
Related Market Intelligence Reports:
Foot and Ankle Devices Market, by Product Type (Bracing and Support Devices, Joint Implants, Soft Tissue Orthopedic Devices, Orthopedic Fixation Devices, and Prosthetics), by Cause of Injury (Trauma, Diabetes, Neurological Disorders, Osteoporosis, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027
Subcutaneous Drug Delivery Market, by Usability (Disposable and Reusable), by Disease Indication (Auto-immune Disorders, Neurological Disorders, Oncology Disorders, Hormonal Disorders, Allergy and Infectious Disorders, Ophthalmic Disorders, and Others), by Delivery Type (Prefilled Syringe, Autoinjector (Spring Type, Motorized Type, and Wearable Type), Prefilled Pen (Disposable and Reusable), Vial (Syringe), and Pump and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.
